Please enable JavaScript to continue using this application.

Compare $TNYA vs $VTVT | Chartloom

Compare

$TNYA vs $VTVT

Tenaya Therapeutics Inc · vTv Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Compare $TNYA vs $VTVT

Comparing Tenaya Therapeutics Inc and vTv Therapeutics Inc

TNYATenaya Therapeutics Inc

VTVTvTv Therapeutics Inc

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

VTVTvTv Therapeutics Inc

Market cap

$123M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

216600.0%

YTD performance

-21.3%

52W performance

38.3%

FCF yield

-13.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TNYA

VTVT

Detailed metrics comparison

TNYA

Tenaya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

TNYA$126M

VTVT$123M

Enterprise Value

TNYA$48M

VTVT$36M

Price

TNYA$0.58

VTVT$31.18

P/E Ratio

TNYAN/A

VTVTN/A

P/S Ratio

TNYA94.33x

VTVT3.33x

EV/Sales

TNYA35.84x

VTVT0.98x

EV/EBITDA

TNYA0.00x

VTVT0.00x

P/B Ratio

TNYA1.82x

VTVT1.53x

P/FCF Ratio

TNYAN/A

VTVTN/A

EV/FCF

TNYA-0.91x

VTVT-2.16x

PEG Ratio

TNYAN/A

VTVTN/A

Forward P/E (NTM)

TNYAN/A

VTVTN/A

Forward P/S (NTM)

TNYA20.11x

VTVTN/A

Revenue (TTM)

TNYA$1M

VTVT$37M

Revenue Growth (YoY)

TNYAN/A

VTVT216600.0%

Forward Rev Growth

TNYA-49.9%

VTVT-97.3%

Gross Margin (TTM)

TNYA0.0%

VTVT0.0%

Operating Margin (TTM)

TNYA0.0%

VTVT63.1%

EBITDA Margin (TTM)

TNYA-5657.2%

VTVT-25.1%

Net Margin (TTM)

TNYA-7724.0%

VTVT-12.9%

FCF Margin (TTM)

TNYA-3939.2%

VTVT-45.5%

Net Income (TTM)

TNYA$-103M

VTVT$-5M

FCF (TTM)

TNYA$-53M

VTVT$-17M

EPS (TTM)

TNYA-$0.47

VTVT-$0.38

ROE (TTM)

TNYA-10805.0%

VTVT-627.0%

ROA (TTM)

TNYA-8584.0%

VTVT-506.0%

ROIC (TTM)

TNYA-10805.0%

VTVT-626.0%

Cash

TNYA$78M

VTVT$87M

Debt

TNYA$0

VTVT$0

Net Cash/Debt

TNYA$78M

VTVT$87M

Current Ratio (TTM)

TNYA4.52x

VTVT12.48x

Quick Ratio (TTM)

TNYA4.34x

VTVT12.42x

Debt/Equity (TTM)

TNYA0.00x

VTVT0.00x

Debt/Assets (TTM)

TNYA0.0%

VTVT0.0%

Interest Coverage (TTM)

TNYAN/A

VTVTN/A

Net Debt/EBITDA (TTM)

TNYA0.00x

VTVT0.00x

Beta

TNYA2.87

VTVT0.23

52W Performance

TNYA-68.3%

VTVT38.3%

YTD Performance

TNYA-21.0%

VTVT-21.3%

% from 52W High

TNYA-75.3%

VTVT-29.1%

% from 52W Low

TNYA11.4%

VTVT59.9%

Asset Turnover (TTM)

TNYA0.00x

VTVT0.37x

FCF Yield (TTM)

TNYA-41.8%

VTVT-13.6%

Earnings Yield (TTM)

TNYA-81.9%

VTVT-3.9%

Dividend Yield (TTM)

TNYAN/A

VTVTN/A

Rule of 40

TNYA-3,939.2

VTVT216,554.5

EV/GP/RG

TNYAN/A

VTVTN/A

Ticker research

View TNYA research View VTVT research

Metric	TNYA Tenaya Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$126M	$123M
Enterprise Value	$48M	$36M
Price	$0.58	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	94.33x	3.33x
EV/Sales	35.84x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.82x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.91x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	20.11x	N/A
Revenue & Growth
Revenue (TTM)	$1M	$37M
Revenue Growth (YoY)	N/A	216600.0%
Forward Rev Growth	-49.9%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-5657.2%	-25.1%
Net Margin (TTM)	-7724.0%	-12.9%
FCF Margin (TTM)	-3939.2%	-45.5%
Net Income (TTM)	$-103M	$-5M
FCF (TTM)	$-53M	$-17M
EPS (TTM)	-$0.47	-$0.38
ROE (TTM)	-10805.0%	-627.0%
ROA (TTM)	-8584.0%	-506.0%
ROIC (TTM)	-10805.0%	-626.0%
Financial Health
Cash	$78M	$87M
Debt	$0	$0
Net Cash/Debt	$78M	$87M
Current Ratio (TTM)	4.52x	12.48x
Quick Ratio (TTM)	4.34x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.87	0.23
52W Performance	-68.3%	38.3%
YTD Performance	-21.0%	-21.3%
% from 52W High	-75.3%	-29.1%
% from 52W Low	11.4%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.37x
FCF Yield (TTM)	-41.8%	-13.6%
Earnings Yield (TTM)	-81.9%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,939.2	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View TNYA research	View VTVT research

Valuation

P/S Ratio

VTVT

3.33x

TNYA

94.33x

EV/FCF

VTVT

-2.16x

TNYA

-0.91x

Growth & revenue

Revenue Growth TTM

VTVT

216600.0%

Forward Revenue Growth

TNYA

-49.9%

VTVT

-97.3%

Profitability & performance

Gross Margin

TNYA

0.0%

VTVT

0.0%

ROE

VTVT

-627.0%

TNYA

-10805.0%

FCF Yield %

VTVT

-13.6%

TNYA

-41.8%

52-Week Performance

VTVT

38.3%

TNYA

-68.3%

Detailed metrics comparison

TNYA

Tenaya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

TNYA$126M

VTVT$123M

Enterprise Value

TNYA$48M

VTVT$36M

Price

TNYA$0.58

VTVT$31.18

P/E Ratio

TNYAN/A

VTVTN/A

P/S Ratio

TNYA94.33x

VTVT3.33x

EV/Sales

TNYA35.84x

VTVT0.98x

EV/EBITDA

TNYA0.00x

VTVT0.00x

P/B Ratio

TNYA1.82x

VTVT1.53x

P/FCF Ratio

TNYAN/A

VTVTN/A

EV/FCF

TNYA-0.91x

VTVT-2.16x

PEG Ratio

TNYAN/A

VTVTN/A

Forward P/E (NTM)

TNYAN/A

VTVTN/A

Forward P/S (NTM)

TNYA20.11x

VTVTN/A

Revenue (TTM)

TNYA$1M

VTVT$37M

Revenue Growth (YoY)

TNYAN/A

VTVT216600.0%

Forward Rev Growth

TNYA-49.9%

VTVT-97.3%

Gross Margin (TTM)

TNYA0.0%

VTVT0.0%

Operating Margin (TTM)

TNYA0.0%

VTVT63.1%

EBITDA Margin (TTM)

TNYA-5657.2%

VTVT-25.1%

Net Margin (TTM)

TNYA-7724.0%

VTVT-12.9%

FCF Margin (TTM)

TNYA-3939.2%

VTVT-45.5%

Net Income (TTM)

TNYA$-103M

VTVT$-5M

FCF (TTM)

TNYA$-53M

VTVT$-17M

EPS (TTM)

TNYA-$0.47

VTVT-$0.38

ROE (TTM)

TNYA-10805.0%

VTVT-627.0%

ROA (TTM)

TNYA-8584.0%

VTVT-506.0%

ROIC (TTM)

TNYA-10805.0%

VTVT-626.0%

Cash

TNYA$78M

VTVT$87M

Debt

TNYA$0

VTVT$0

Net Cash/Debt

TNYA$78M

VTVT$87M

Current Ratio (TTM)

TNYA4.52x

VTVT12.48x

Quick Ratio (TTM)

TNYA4.34x

VTVT12.42x

Debt/Equity (TTM)

TNYA0.00x

VTVT0.00x

Debt/Assets (TTM)

TNYA0.0%

VTVT0.0%

Interest Coverage (TTM)

TNYAN/A

VTVTN/A

Net Debt/EBITDA (TTM)

TNYA0.00x

VTVT0.00x

Beta

TNYA2.87

VTVT0.23

52W Performance

TNYA-68.3%

VTVT38.3%

YTD Performance

TNYA-21.0%

VTVT-21.3%

% from 52W High

TNYA-75.3%

VTVT-29.1%

% from 52W Low

TNYA11.4%

VTVT59.9%

Asset Turnover (TTM)

TNYA0.00x

VTVT0.37x

FCF Yield (TTM)

TNYA-41.8%

VTVT-13.6%

Earnings Yield (TTM)

TNYA-81.9%

VTVT-3.9%

Dividend Yield (TTM)

TNYAN/A

VTVTN/A

Rule of 40

TNYA-3,939.2

VTVT216,554.5

EV/GP/RG

TNYAN/A

VTVTN/A

Ticker research

View TNYA research View VTVT research

Metric	TNYA Tenaya Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$126M	$123M
Enterprise Value	$48M	$36M
Price	$0.58	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	94.33x	3.33x
EV/Sales	35.84x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.82x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.91x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	20.11x	N/A
Revenue & Growth
Revenue (TTM)	$1M	$37M
Revenue Growth (YoY)	N/A	216600.0%
Forward Rev Growth	-49.9%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-5657.2%	-25.1%
Net Margin (TTM)	-7724.0%	-12.9%
FCF Margin (TTM)	-3939.2%	-45.5%
Net Income (TTM)	$-103M	$-5M
FCF (TTM)	$-53M	$-17M
EPS (TTM)	-$0.47	-$0.38
ROE (TTM)	-10805.0%	-627.0%
ROA (TTM)	-8584.0%	-506.0%
ROIC (TTM)	-10805.0%	-626.0%
Financial Health
Cash	$78M	$87M
Debt	$0	$0
Net Cash/Debt	$78M	$87M
Current Ratio (TTM)	4.52x	12.48x
Quick Ratio (TTM)	4.34x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.87	0.23
52W Performance	-68.3%	38.3%
YTD Performance	-21.0%	-21.3%
% from 52W High	-75.3%	-29.1%
% from 52W Low	11.4%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.37x
FCF Yield (TTM)	-41.8%	-13.6%
Earnings Yield (TTM)	-81.9%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,939.2	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View TNYA research	View VTVT research